ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 235 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $6,672,000 | -8.9% | 653,440 | +17.5% | 0.01% | -11.1% |
Q3 2016 | $7,324,000 | +4.0% | 556,098 | +0.3% | 0.01% | 0.0% |
Q2 2016 | $7,044,000 | -0.7% | 554,652 | +3.3% | 0.01% | 0.0% |
Q1 2016 | $7,094,000 | -14.1% | 537,004 | +0.0% | 0.01% | -18.2% |
Q4 2015 | $8,256,000 | +23.8% | 536,786 | -0.2% | 0.01% | +22.2% |
Q3 2015 | $6,670,000 | -1.4% | 537,900 | +8.7% | 0.01% | +12.5% |
Q2 2015 | $6,767,000 | +19.0% | 494,700 | +4.1% | 0.01% | +14.3% |
Q1 2015 | $5,686,000 | -6.3% | 475,399 | +0.0% | 0.01% | -12.5% |
Q4 2014 | $6,068,000 | -5.7% | 475,167 | -0.9% | 0.01% | -11.1% |
Q3 2014 | $6,434,000 | -12.0% | 479,642 | +5.3% | 0.01% | -10.0% |
Q2 2014 | $7,309,000 | -13.1% | 455,385 | -2.4% | 0.01% | -16.7% |
Q1 2014 | $8,415,000 | +15.8% | 466,721 | -0.7% | 0.01% | +9.1% |
Q4 2013 | $7,265,000 | +3.6% | 469,909 | -0.3% | 0.01% | -8.3% |
Q3 2013 | $7,010,000 | +13.6% | 471,427 | -1.2% | 0.01% | +9.1% |
Q2 2013 | $6,172,000 | – | 476,982 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLENHILL ADVISORS LLC | 7,659,841 | $78,207,000 | 5.54% |
Tamarack Advisers, LP | 765,000 | $7,811,000 | 5.52% |
Rovida Advisors Inc. | 1,501,900 | $15,334,000 | 3.41% |
Blue Harbour Group | 9,309,695 | $95,052,000 | 3.18% |
Casdin Capital, LLC | 280,000 | $2,859,000 | 2.36% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 1,988,300 | $20,301,000 | 1.97% |
Adirondack Research & Management Inc. | 555,661 | $5,673,000 | 1.93% |
BROADVIEW ADVISORS LLC | 1,006,550 | $10,277,000 | 1.37% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 13,268,624 | $135,473,000 | 1.25% |
FULLER & THALER ASSET MANAGEMENT, INC. | 4,627,481 | $47,247,000 | 0.71% |